For Innovators
Innovators play a crucial role in transforming ideas into impactful solutions. Cimit and its partners are dedicated to fostering a vibrant ecosystem where creativity meets practical application.
We regularly launch programs, provide funding opportunities, and host events designed specifically for innovators. Whether you’re an entrepreneur, researcher, academic investigator, or clinician, there are numerous ways to engage with Cimit.
Current Funding Opportunities
Explore our current funding opportunities to support your next health technology project. Many opportunities not only provide financial resources but also include mentorship, education, and guidance to help advance your project toward commercialization.
Independent Test Assessment Program (ITAP)
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.
Current Funding Opportunities
Please sign up for our newsletter to be notified when new opportunities are launched.
Independent Test Assessment Program (ITAP) for Multiplex POC and OTC Diagnostics for COVID-19 and Flu
In partnership with the FDA, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Rapid Acceleration of Diagnostics (RADx®) Tech program is soliciting proposals to accelerate the validation, 510(k) submission, and commercialization of innovative point-of-care (POC) and over-the-counter (OTC) multiplex tests that can detect at-minimum COVID-19, Flu A and Flu B. Tests that include additional respiratory targets (e.g., H5N1, RSV) are encouraged.
Past Funding Opportunities
RADx® Tech Independent Test Assessment Program (ITAP) for Hepatitis B Virus Surface Antigen (HBsAg) Point-of-Care (POC)* Diagnostics
In collaboration with the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program sought proposals to accelerate the validation, regulatory authorization, and commercialization of innovative point-of-care (POC) tests for hepatitis B virus surface antigen (HBsAg) detection. ITAP is not presently accepting new applications for Hepatitus B Virus POC Diagnostics.
ITAP for Diagnostic Mpox Lesion Panel
ITAP is not presently accepting new applications for Mpox Lesion Panel. Applications that were submitted by the deadline that meet all the previous eligibility criteria will be reviewed.
COVID-19 Tests
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable over-the-counter COVID-19 tests to the public. ITAP is not presently accepting new applications for COVID-19 tests.
Multiplex Point-of-Care (POC) Diagnostic Tests
ITAP is not presently accepting new applications for multiplex point-of-care diagnostics tests. Applications that were submitted by December 16, 2022 that meet all the previous eligibility criteria will be reviewed.
MPox Virus Tests
ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to October 17, 2022 that meet all the previous eligibility criteria will be reviewed.
Hepatitis C Virus Point-Of-Care Diagnostics
ITAP is not presently accepting new applications for Hepatitis C diagnostics. Applications that were submitted prior to March 12, 2023 that meet all the previous eligibility criteria will be reviewed.
Multiplex Over-the-Counter (OTC) Diagnostic Tests for COVID-19 and Flu
ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to May 3, 2023 that meet all the previous eligibility criteria will be reviewed.
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.
Current Funding Opportunities
Please sign up for our newsletter to be notified when new opportunities are launched.
Independent Test Assessment Program (ITAP) for Multiplex POC and OTC Diagnostics for COVID-19 and Flu
In partnership with the FDA, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Rapid Acceleration of Diagnostics (RADx®) Tech program is soliciting proposals to accelerate the validation, 510(k) submission, and commercialization of innovative point-of-care (POC) and over-the-counter (OTC) multiplex tests that can detect at-minimum COVID-19, Flu A and Flu B. Tests that include additional respiratory targets (e.g., H5N1, RSV) are encouraged.
Past Funding Opportunities
RADx® Tech Independent Test Assessment Program (ITAP) for Hepatitis B Virus Surface Antigen (HBsAg) Point-of-Care (POC)* Diagnostics
In collaboration with the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program sought proposals to accelerate the validation, regulatory authorization, and commercialization of innovative point-of-care (POC) tests for hepatitis B virus surface antigen (HBsAg) detection. ITAP is not presently accepting new applications for Hepatitus B Virus POC Diagnostics.
ITAP for Diagnostic Mpox Lesion Panel
ITAP is not presently accepting new applications for Mpox Lesion Panel. Applications that were submitted by the deadline that meet all the previous eligibility criteria will be reviewed.
COVID-19 Tests
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable over-the-counter COVID-19 tests to the public. ITAP is not presently accepting new applications for COVID-19 tests.
Multiplex Point-of-Care (POC) Diagnostic Tests
ITAP is not presently accepting new applications for multiplex point-of-care diagnostics tests. Applications that were submitted by December 16, 2022 that meet all the previous eligibility criteria will be reviewed.
MPox Virus Tests
ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to October 17, 2022 that meet all the previous eligibility criteria will be reviewed.
Hepatitis C Virus Point-Of-Care Diagnostics
ITAP is not presently accepting new applications for Hepatitis C diagnostics. Applications that were submitted prior to March 12, 2023 that meet all the previous eligibility criteria will be reviewed.
Multiplex Over-the-Counter (OTC) Diagnostic Tests for COVID-19 and Flu
ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to May 3, 2023 that meet all the previous eligibility criteria will be reviewed.
Recent News and Awards
Join Us
Become part of a thriving community that is reshaping the future of health. Together, we can drive meaningful change and improve outcomes for all.
For more information, please sign up for our emails or connect with us on social media to stay updated on the latest opportunities and events.